James Conjulus
Analyst
Stifel
Equibles does not estimate personal net worth.
About James Conjulus
James Conjulus is recorded as Analyst at Stifel. James Conjulus has spoken on 1 earnings call across 1 company, most recently for Mirum Pharmaceuticals, Inc. on November 3, 2026. The companies whose calls James Conjulus spoke on are classified in the Healthcare sector.
James Conjulus on recent calls
“Hey, thanks for taking my question, and maybe just one more on PSE and appreciate, you know, there's only so much you can say, but, you know, I think you've mentioned in the past that in the discussion with the FDA, there was nothing really new you felt was new that wasn't already in the original VISTA study, and, you…”
Affiliation history
-
Stifel
Analyst
Transcript header (unverified)
Current